BAT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.538600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.822360E-01
Normal-vs-Stage2
2.593800E-01
Normal-vs-Stage3
9.592100E-02
Normal-vs-Stage4
9.384000E-01
Stage1-vs-Stage2
7.142600E-01
Stage1-vs-Stage3
1.766760E-01
Stage1-vs-Stage4
5.612100E-02
Stage2-vs-Stage3
1.084250E-01
Stage2-vs-Stage4
2.233200E-01
Stage3-vs-Stage4
2.030100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.498000E-01
Normal-vs-AfricanAmerican
3.843400E-01
Normal-vs-Asian
4.133000E-01
Caucasian-vs-AfricanAmerican
8.493600E-01
Caucasian-vs-Asian
9.439400E-01
AfricanAmerican-vs-Asian
9.195400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.040600E-01
Normal-vs-Female
2.152800E-01
Male-vs-Female
7.611000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.949400E-01
Normal-vs-Age(41-60Yrs)
2.662000E-01
Normal-vs-Age(61-80Yrs)
2.323600E-01
Normal-vs-Age(81-100Yrs)
4.823000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.197400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.573420E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.765400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.923700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.041400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.892200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.907590E-01
Normal-vs-Daily Drinker
3.794300E-02
Normal-vs-Weekly Drinker
4.850800E-01
Normal-vs-Occasional Drinker
6.138800E-01
Normal-vs-Social Drinker
2.643400E-01
Non Drinker-vs-Daily Drinker
2.881400E-01
Non Drinker-vs-Weekly Drinker
2.271400E-01
Non Drinker-vs-Occasional Drinker
8.043900E-02
Non Drinker-vs-Social Drinker
3.485400E-01
Daily Drinker-vs-Weekly Drinker
2.560500E-02
Daily Drinker-vs-Occasional Drinker
4.976800E-03
Daily Drinker-vs-Social Drinker
3.346000E-02
Weekly Drinker-vs-Occasional Drinker
6.921600E-01
Weekly Drinker-vs-Social Drinker
7.029400E-01
Occasional Drinker-vs-Social Drinker
3.962800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.165800E-01
Normal-vs-Grade 2
5.871200E-01
Normal-vs-Grade 3
1.113950E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.403700E-02
Grade 1-vs-Grade 3
1.471780E-01
Grade 1-vs-Grade 4
3.165800E-01
Grade 2-vs-Grade 3
9.512200E-01
Grade 2-vs-Grade 4
5.871200E-01
Grade 3-vs-Grade 4
1.113950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.216800E-01
Normal-vs-NonDiabetic
2.055400E-01
Diabetic-vs-NonDiabetic
9.197600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.558780E-01
Normal-vs-NoPancreatitis
2.353400E-01
Pancreatitis-vs-NoPancreatitis
7.253000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.362800E-01
Normal-vs-N1
2.567200E-01
N0-vs-N1
9.099200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.610400E-01
Normal-vs-TP53-NonMutant
3.943800E-01
TP53-Mutant-vs-TP53-NonMutant
5.902200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
